Maternal serum pregnancy-associated plasma protein A (PAPP-A) but not pregnancy-specific β1-glycoprotein (SP1) is a useful second-trimester marker for fetal trisomy 18
Authors:
- N. LeporrierNLN. Leporrier
- M. HerrouMHM. Herrou
- P. LeymariePLP. Leymarie
- 1 June 1999
- journal article
- Published by Wiley in Prenatal Diagnosis
- Vol. 19 (6) , 537-541
Abstract
The usefulness of early second-trimester serum determinations of pregnancy-associated plasma protein A (PAPP-A) and pregnancy-specific beta1-glycoprotein (SP1) in suspected cases of fetal trisomy 18 was examined in a retrospective, cross-sectional study. Maternal serum PAPP-A and SP1 in 20 cases of fetal trisomy 18 between 15 and 20 weeks of pregnancy, and in 40 controls matched for gestational age and storage time were determined and compared with hCG and free oestriol (uE3). In trisomy 18, the reduction in serum concentration was found to be more pronounced for PAPP-A than for hCG and free oestriol. While none of the 40 control sera had a MoM below 0.2 for either PAPP-A, hCG or uE3, in the trisomy 18 group (20 cases) 17 (85 per cent) of the PAPP-A but only 5 (25 per cent) of the hCG and 4 (20 per cent) of the uE3 results were below the 0.2 MoM threshold. SP1 did not distinguish between controls and trisomy 18. This chromosomal abnormality is too rare a condition to justify maternal serum PAPP-A determination in the second trimester as a routine procedure, but such a test can play a useful role whenever the risk of trisomy 18 is found to be only marginally increased after hCG and uE3 measurements.Keywords
This publication has 26 references indexed in Scilit:
- SCHWANGERSCHAFTSPROTEIN 1 (SP1) AS A MATERNAL SERUM MARKER FOR DOWN SYNDROME IN THE FIRST AND SECOND TRIMESTERSPrenatal Diagnosis, 1997
- Risk‐based prenatal screening for trisomy 18 using alpha‐fetoprotein, unconjugated oestriol and human chorionic gonadotropinPrenatal Diagnosis, 1995
- A sensitive enzyme immunoassay for pregnancy-associated plasma protein A (PAPP-A): a possible first trimester method of screening for Down syndrome and other trisomiesArchives of Gynecology and Obstetrics, 1995
- Serum PAPP‐A and free β‐hCG are first‐trimester screening markers for down syndromePrenatal Diagnosis, 1994
- Serum PAPP‐A levels are depressed in women with fetal Down syndrome in early pregnancyPrenatal Diagnosis, 1993
- Pregnancy associated plasma protein A as a marker for Down syndrome in the second trimester of pregnancyPrenatal Diagnosis, 1993
- Screening for fetal Down syndrome with maternal serum hCG and oestriol: A prospective studyPrenatal Diagnosis, 1992
- Prenatal screening for chromosome abnormalities using maternal serum chorionic gonadotrophin, alpha‐fetoprotein, and agePrenatal Diagnosis, 1991
- Prenatal screening for trisomy 18 in the second trimesterPrenatal Diagnosis, 1990
- First‐trimester maternal serum biochemical indicators in Down syndromePrenatal Diagnosis, 1990